1. Executive Summary2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction And Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Pharmacogenomics Market Definition And Segmentations
6.4. Market Segmentation By Technology
6.4.1. Next Generation Sequencing
6.4.2. Polymerase Chain Reaction
6.4.3. Gel Electrophoresis
6.4.4. Mass Spectrometry
6.4.5. Microarray
6.4.6. Other Technologies
6.5. Market Segmentation By Application
6.5.1. Neurological Diseases
6.5.2. Infectious Diseases
6.5.3. Oncology
6.5.4. Cardiovascular Diseases
6.5.5. Pain Management
6.5.6. Other Applications
6.6. Market Segmentation By End User
6.6.1. Hospitals And Clinics
6.6.2. Research Institutions
6.6.3. Academic Institutes
6.6.4. Other End Users
7. Major Market Trends
7.1. Launch Of Genome Editing Solution For Deeper Analysis Of Advanced Therapies
7.2. Focus On Integration Of Artificial Intelligence (AI) In Genomics To Analyze Genetic Data
7.3. Growing Advancements In Metagenomics
7.4. Strategic Partnerships And Collaborations Among Market Players
7.5. Introduction Of Three-Dimensional (3D) Genomics To Study Influences On Gene Expression And Function
7.6. New Product Innovations With Focus On Infectious Diseases And Gene Editing
7.7. Development Of Psychotropic Pharmacogenomics Test For Informed Decisions
8. Pharmacogenomics Market – Macro-Economic Scenario
8.1. COVID-19 Impact On The Pharmacogenomics Market
8.2. Impact Of The War In Ukraine On The Pharmacogenomics Market
8.3. Impact Of High Inflation On The Pharmacogenomics Market
9. Global Market Size and Growth
9.1. Market Size
9.2. Historic Market Growth, 2017 – 2022, Value ($ Million)
9.2.1. Market Drivers 2017 – 2022
9.2.2. Market Restraints 2017 – 2022
9.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
9.3.1. Market Drivers 2022 – 2027
9.3.2. Market Restraints 2022 – 2027
10. Global Pharmacogenomics Market Segmentation
10.1. Global Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10.2. Global Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10.3. Global Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11. Pharmacogenomics Market, Regional and Country Analysis
11.1. Global Pharmacogenomics Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.2. Global Pharmacogenomics Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12. Asia-Pacific Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory Bodies
12.2.7. Major Associations
12.2.8. Taxes Levied
12.2.9. Corporate Tax Structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Asia-Pacific Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.4. Asia-Pacific Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.5. Asia-Pacific Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.6. Asia-Pacific Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.7. Asia-Pacific Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.8. Asia-Pacific Pharmacogenomics Market: Country Analysis
12.9. China Market
12.10. Summary
12.11. Market Overview
12.11.1. Country Information
12.11.2. Market Information
12.11.3. Background Information
12.11.4. Government Initiatives
12.11.5. Regulations
12.11.6. Regulatory Bodies
12.11.7. Major Associations
12.11.8. Taxes Levied
12.11.9. Corporate Tax Structure
12.11.10. Investments
12.11.11. Major Companies
12.12. China Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.13. China Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.14. China Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.15. China Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.16. China Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.17. India Market
12.18. India Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.19. India Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.20. India Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.21. India Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.22. India Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.23. Japan Market
12.24. Japan Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.25. Japan Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.26. Japan Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.27. Japan Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.28. Japan Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.29. Australia Market
12.30. Australia Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.31. Australia Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.32. Australia Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.33. Australia Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.34. Australia Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.35. Indonesia Market
12.36. Indonesia Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.37. Indonesia Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.38. Indonesia Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.39. Indonesia Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.40. Indonesia Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.41. South Korea Market
12.42. South Korea Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.43. South Korea Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.44. South Korea Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.45. South Korea Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.46. South Korea Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13. Western Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Western Europe Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.4. Western Europe Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.5. Western Europe Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.6. Western Europe Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.7. Western Europe Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.8. Western Europe Pharmacogenomics Market: Country Analysis
13.9. UK Market
13.10. UK Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.11. UK Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.12. UK Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.13. UK Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.14. UK Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.15. Germany Market
13.16. Germany Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.17. Germany Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.18. Germany Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.19. Germany Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.20. Germany Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.21. France Market
13.22. France Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.23. France Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.24. France Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.25. France Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.26. France Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14. Eastern Europe Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes Levied
14.2.9. Corporate Tax Structure
14.2.10. Investment
14.2.11. Major Companies
14.3. Eastern Europe Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.4. Eastern Europe Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.5. Eastern Europe Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.6. Eastern Europe Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.7. Eastern Europe Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.8. Eastern Europe Pharmacogenomics Market: Country Analysis
14.9. Russia Market
14.10. Russia Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.11. Russia Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.12. Russia Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.13. Russia Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.14. Russia Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15. North America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. North America Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.4. North America Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.5. North America Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.6. North America Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.7. North America Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.8. North America Pharmacogenomics Market: Country Analysis
15.9. USA Market
15.10. Summary
15.11. Market Overview
15.11.1. Country Information
15.11.2. Market Information
15.11.3. Background Information
15.11.4. Government Initiatives
15.11.5. Regulations
15.11.6. Regulatory Bodies
15.11.7. Major Associations
15.11.8. Taxes Levied
15.11.9. Corporate Tax Structure
15.11.10. Investments
15.11.11. Major Companies
15.12. USA Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.13. USA Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.14. USA Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.15. USA Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.16. USA Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16. South America Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. South America Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
16.4. South America Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
16.5. South America Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.6. South America Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.7. South America Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.8. South America Pharmacogenomics Market: Country Analysis
16.9. Brazil Market
16.10. Brazil Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
16.11. Brazil Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
16.12. Brazil Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.13. Brazil Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.14. Brazil Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17. Middle East Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Middle East Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
17.4. Middle East Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
17.5. Middle East Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.6. Middle East Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.7. Middle East Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
18. Africa Market
18.1. Summary
18.2. Market Overview
18.2.1. Region Information
18.2.2. Market Information
18.2.3. Background Information
18.2.4. Government Initiatives
18.2.5. Regulations
18.2.6. Regulatory Bodies
18.2.7. Major Associations
18.2.8. Taxes Levied
18.2.9. Corporate Tax Structure
18.2.10. Investments
18.2.11. Major Companies
18.3. Africa Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
18.4. Africa Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
18.5. Africa Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
18.6. Africa Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
18.7. Africa Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
19. Competitive Landscape And Company Profiles
19.1. Company Profiles
19.2. Illumina Inc
19.2.1. Company Overview
19.2.2. Products And Services
19.2.3. Business Strategy
19.2.4. Financial Overview
19.3. Eurofins Scientific SE
19.3.1. Company Overview
19.3.2. Products And Services
19.3.3. Business Strategy
19.3.4. Financial Overview
19.4. Myriad Genetics Inc
19.4.1. Company Overview
19.4.2. Products And Services
19.4.3. Business Strategy
19.4.4. Financial Overview
19.5. PerkinElmer Inc
19.5.1. Company Overview
19.5.2. Products And Services
19.5.3. Business Strategy
19.5.4. Financial Overview
19.6. Centogene N.V
19.6.1. Company Overview
19.6.2. Products And Services
19.6.3. Business Strategy
19.6.4. Financial Overview
20. Key Mergers And Acquisitions
20.1. Genomenon, Inc Acquired Boston Genetics
20.2. Incite Health PTY Limited Acquired CNSDose
20.3. Moderna Acquired OriCiro Genomics
20.4. RetinalGenix Technologies Acquired DNA/GPS
20.5. Castle Biosciences, Inc Acquired AltheaDx
20.6. LetsGetChecked Announced Acquisition Of Veritas Genetics And Veritas Intercontinental
20.7. Element Biosciences Acquired Loop Genomics
20.8. Invitae Corporation Acquired YouScript, Inc And Genelex
21. Opportunities And Strategies
21.1. Global Pharmacogenomics Market In 2027 – Countries Offering Most New Opportunities
21.2. Global Pharmacogenomics Market In 2027 – Segments Offering Most New Opportunities
21.3. Global Pharmacogenomics Market In 2027 – Growth Strategies
21.3.1. Market Trend Based Strategies
21.3.2. Competitor Strategies
22. Pharmacogenomics Market, Conclusions And Recommendations
22.1. Conclusions
22.2. Recommendations
22.2.1. Product
22.2.2. Place
22.2.3. Price
22.2.4. Promotion
22.2.5. People
23. Appendix
23.1. Market Data Sources
23.2. Research Methodology
23.3. Currencies
23.4. The Business Research Company
23.5. Copyright and Disclaimer